Literature DB >> 17464556

Triple site biventricular pacing in a patient with congestive heart failure and severe mechanical dyssynchrony.

Radosław Lenarczyk1, Oskar Kowalski, Patrycja Pruszkowska-Skrzep, Tomasz Kukulski, Sławomir Pluta, Mariola Szulik, Jacek Kowalczyk, Zbigniew Kalarus.   

Abstract

We report on a case of a 62-year-old patient with symptomatic heart failure and severe ventricular electrical and mechanical dyssynchrony, who was implanted percutaneously with a triple site (dual-left single-right) resynchronization device. At 3-months follow-up, the patient's functional status improved significantly as shown by subjective and objective tests. Furthermore, this mode of pacing has allowed nearly complete inter- and intraventricular mechanical resynchronization.

Entities:  

Mesh：

Year:  2007        PMID： 17464556     DOI： 10.1007/s10840-007-9090-4

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


  8 in total

1.  Cardiac pacing in heart failure patients with left bundle branch block: impact of pacing site for optimizing left ventricular resynchronization.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; S Gulletta; A Salvati; C Dicandia; V Santinelli; P Mazzone; F Veglia; J Ding; L Sallusti; J Spinelli; G Vicedomini
Journal:  Ital Heart J       Date:  2000-07

2.  Electrical characteristics of a split cathodal pacing configuration.

Authors:  Marc W Mayhew; Jane E Slabaugh; Rosemary S Bubien; G Neal Kay
Journal:  Pacing Clin Electrophysiol       Date:  2003-12       Impact factor: 1.976

3.  Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure.

Authors:  Massimo Sassara; Augusto Achilli; Stefano Bianchi; Sabina Ficili; Antonino Marullo; Daniele Pontillo; Paola Achilli; Carlo Peraldo; Fabrizio Sgreccia
Journal:  Pacing Clin Electrophysiol       Date:  2004-06       Impact factor: 1.976

4.  Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure.

Authors:  Cheuk-Man Yu; Elaine Chau; John E Sanderson; Katherine Fan; Man-Oi Tang; Wing-Hong Fung; Hong Lin; Shun-Ling Kong; Yui-Ming Lam; Michael R S Hill; Chu-Pak Lau
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Authors:  Jeroen J Bax; Gabe B Bleeker; Thomas H Marwick; Sander G Molhoek; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

6.  Elevations in ventricular pacing threshold with the use of the Y adaptor: implications for biventricular pacing.

Authors:  Robert W Rho; Vickas V Patel; Edward P Gerstenfeld; Sanjay Dixit; Joseph W Poku; Heather M Ross; David Callans; Dusan Z Kocovic
Journal:  Pacing Clin Electrophysiol       Date:  2003-03       Impact factor: 1.976

7.  Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.

Authors:  Gabe B Bleeker; Theodorus A M Kaandorp; Hildo J Lamb; Eric Boersma; Paul Steendijk; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

8.  Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

Authors:  Cheuk-Man Yu; Wing-Hong Fung; Hong Lin; Qing Zhang; John E Sanderson; Chu-Pak Lau
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778
  8 in total
  1 in total

1.  Triple-site pacing: a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy.

Authors:  Takashi Nishimura; Shunei Kyo
Journal:  J Artif Organs       Date:  2010-02-20       Impact factor: 1.731
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.